Ursolic Acid Analogs as Potential Therapeutics for Cancer
Open Access
Abstract
Ursolic acid (UA) is a pentacyclic triterpene isolated from a large variety of vegetables, fruits and many traditional medicinal plants. It is a structural isomer of Oleanolic Acid. The medicinal application of UA has been explored extensively over the last two decades. The diverse pharmacological properties of UA include anti-inflammatory, antimicrobial, antiviral, antioxidant, anti-proliferative, etc. Especially, UA holds a promising position, potentially, as a cancer preventive and therapeutic agent due to its relatively non-toxic properties against normal cells but its antioxidant and antiproliferative activities against cancer cells. Cell culture studies have shown interference of UA with multiple pharmacological and molecular targets that play a critical role in many cells signaling pathways. Although UA is considered a privileged natural product, its clinical applications are limited due to its low absorption through the gastro-intestinal track and rapid elimination. The low bioavailability of UA limits its use as a therapeutic drug. To overcome these drawbacks and utilize the importance of the scaffold, many researchers have been engaged in designing and developing synthetic analogs of UA via structural modifications. This present review summarizes the synthetic UA analogs and their cytotoxic antiproliferative properties reported in the last two decades.Keywords
Funding Information
- Pilot Study Research Program (PSRP), Augusta University (I01BX-003862)
- Veterans Health Administration Office of Research and Development Merit Award (I01BX-003862)
- J.H. Harrison Endowment funds (I01BX-003862)
- Augusta University New Investigator Startup funds (I01BX-003862)
This publication has 128 references indexed in Scilit:
- Polyamines and cancer: implications for chemotherapy and chemopreventionExpert Reviews in Molecular Medicine, 2013
- Synthesis and Cytotoxic Activity of Ursolic Acid DerivativesZeitschrift für Naturforschung B, 2013
- A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumorsInternational Journal of Nanomedicine, 2013
- Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moietyEuropean Journal of Medicinal Chemistry, 2012
- Synthesis and evaluation of ursolic acid derivatives as potent cytotoxic agentsBioorganic & Medicinal Chemistry Letters, 2012
- Ursolic Acid Inhibits the Initiation, Progression of Prostate Cancer and Prolongs the Survival of TRAMP Mice by Modulating Pro-Inflammatory PathwaysPLOS ONE, 2012
- Anti-Inflammatory Drug Design Using a Molecular Hybridization ApproachPharmaceuticals, 2011
- Synthesis and in vitro Cytotoxicity of Novel Ursolic Acid DerivativesMolecules, 2010
- Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerNature Reviews Cancer, 2007
- Ursolic acid, a naturally occurring triterpenoid, demonstrates anticancer activity on human prostate cancer cellsJournal of Cancer Research and Clinical Oncology, 2007